Celularity Inc (CELU)
2.76
-0.09
(-3.16%)
USD |
NASDAQ |
Nov 22, 16:00
2.77
+0.01
(+0.36%)
After-Hours: 20:00
Celularity Net Income (Quarterly): -6.488M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -6.488M |
March 31, 2024 | -22.01M |
December 31, 2023 | 9.547M |
September 30, 2023 | -93.88M |
June 30, 2023 | -47.95M |
March 31, 2023 | -64.02M |
December 31, 2022 | 24.43M |
September 30, 2022 | 4.799M |
June 30, 2022 | 47.83M |
Date | Value |
---|---|
March 31, 2022 | -62.87M |
December 31, 2021 | -4.04M |
September 30, 2021 | 49.94M |
June 30, 2021 | -64.48M |
March 31, 2021 | -81.54M |
December 31, 2020 | 3.91M |
September 30, 2020 | -46.32M |
June 30, 2020 | -12.11M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-93.88M
Minimum
Sep 2023
49.94M
Maximum
Sep 2021
-21.49M
Average
-12.11M
Median
Jun 2020
Net Income (Quarterly) Benchmarks
Eli Lilly and Co | 970.30M |
Dentsply Sirona Inc | -494.00M |
Ligand Pharmaceuticals Inc | -7.172M |
NovaBay Pharmaceuticals Inc | -1.212M |
Palatin Technologies Inc | -7.824M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 12.11M |
Total Expenses (Quarterly) | 22.29M |
EPS Diluted (Quarterly) | -0.30 |
Enterprise Value | 101.21M |
Gross Profit Margin (Quarterly) | 82.47% |
Profit Margin (Quarterly) | -53.57% |
Earnings Yield | -211.5% |
Normalized Earnings Yield | -51.19 |